Literature DB >> 21623858

Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease.

R A Alwani1, W W de Herder, F H de Jong, S W J Lamberts, A J van der Lely, R A Feelders.   

Abstract

OBJECTIVE: The aim of this study was to investigate the effects of transsphenoidal surgery (TS) on the adrenal sensitivity to ACTH (adrenocorticotropin) stimulation in patients with Cushing's disease (CD).
METHODS: We measured the cortisol response to 1 μg synthetic ACTH (1-24) 6 days after pituitary surgery in 45 patients with CD. Mean follow-up period was 56·5 months (SE 4·7).
RESULTS: In 24 of 28 patients in sustained remission after pituitary surgery, peak cortisol concentrations below 774 nm (28·0 μg/dl) were recorded after stimulation with 1 μg synthetic ACTH (86%). Two patients with recurrent disease after initial remission (late relapse) also showed ACTH-stimulated peak cortisol levels below 774 nM. Fourteen of 15 patients with persistent CD after surgery (early failure) showed absolute peak cortisol levels >774 nm in response to ACTH stimulation.
CONCLUSION: Patients in remission after pituitary surgery for CD showed a rapid decrease of adrenal responsiveness to exogenous ACTH stimulation. This phenomenon may be explained by ACTH-receptor down-regulation in the adrenal cortex after complete removal of the pituitary corticotroph adenoma. In our study, the postoperative low-dose ACTH stimulation test had a sensitivity of 93% and a specificity of 87% in predicting immediate remission of CD after pituitary surgery.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623858     DOI: 10.1111/j.1365-2265.2011.04130.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.

Authors:  C de Bruin; L J Hofland; L K Nieman; P M van Koetsveld; A M Waaijers; D M Sprij-Mooij; M van Essen; S W J Lamberts; W W de Herder; R A Feelders
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

2.  Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.

Authors:  Nadia Hameed; Chris G Yedinak; Jessica Brzana; Sakir H Gultekin; Nicholas D Coppa; Aclan Dogan; Johnny B Delashaw; Maria Fleseriu
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

3.  Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing's Disease.

Authors:  Q Cui; D Liu; B Xiang; Q Sun; L Fan; M He; Y Wang; X Zhu; H Ye
Journal:  Int J Endocrinol       Date:  2021-09-03       Impact factor: 3.257

4.  Feasibility of endoscopic endonasal approach for recurrent pituitary adenomas after microscopic trans-sphenoidal approach.

Authors:  Joo Min Hwang; Yong Hwy Kim; Jin Wook Kim; Dong Gyu Kim; Hee-Won Jung; Young Seob Chung
Journal:  J Korean Neurosurg Soc       Date:  2013-10-31

5.  ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.

Authors:  Johannes Hofland; Leo J Hofland; Peter M van Koetsveld; Jacobie Steenbergen; Wouter W de Herder; Casper H van Eijck; Ronald R de Krijger; Francien H van Nederveen; Maarten O van Aken; Johannes W de Groot; Thera P Links; Frank H de Jong; Richard A Feelders
Journal:  Orphanet J Rare Dis       Date:  2013-09-13       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.